Finbrom Eye Drop contains Bromfenac 0.09% w/v, a nonsteroidal anti-inflammatory drug (NSAID) specifically formulated for ophthalmic use. It is primarily indicated for the treatment of inflammation and pain associated with ocular surgery, such as cataract extraction, and for the management of postoperative inflammation. Bromfenac works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), which play a key role in the synthesis of prostaglandins, thereby reducing inflammation, pain, and swelling in the eye. Finbrom Eye Drop is typically administered as one or two drops in the affected eye(s) twice daily, starting 24 hours before surgery and continuing for up to two weeks postoperatively, or as directed by a healthcare professional. It is well-tolerated with minimal systemic absorption, reducing the risk of systemic side effects. Patients should avoid touching the dropper tip to the eye or any surface to prevent contamination. Common side effects may include mild burning or stinging upon instillation, eye irritation, or dryness. Finbrom Eye Drop should be used with caution in patients with known hypersensitivity to bromfenac or other NSAIDs. It is important to follow the prescribed dosage and consult an ophthalmologist if symptoms persist or worsen.